Aspen Pharmacare Holdings Limited
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Aspen Pharmacare Holdings Limited's past years’ income statements indicate that its last revenue has increased compared to the previous period by 1852% to $44,706,000,000. The net income raised on $4,404,000,000 and profit margin reached 10%. Total operating expenses were $12,456,000,000.

Profit Margin

Aspen Pharmacare Holdings Limited (OTC:APNHY): Profit margin
2015 36.1B 5.2B 14.4%
2016 2.46B 297.38M 12.08%
2017 3.03B 375.46M 12.38%
2018 2.97B 469.13M 15.76%
2019 2.50B 149.23M 5.96%
2020 2.14B 310.07M 14.43%
2021 2.45B 286.03M 11.67%
2022 2.53B 426.24M 16.81%
2023 2.29B 294.15M 12.84%
2024 44.70B 4.40B 9.85%

APNHY Income Statement (2015 – 2024)

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue
Revenue
44.70B2.29B2.53B2.45B2.14B2.50B2.97B3.03B2.46B36.1B
Cost of revenue
25.25B1.26B1.38B1.35B1.10B1.23B1.49B1.56B1.27B18.8B
Gross profit
19.45B1.02B1.15B1.09B1.03B1.27B1.48B1.46B1.18B17.3B
Operating exp.
Research and development
162M214M433M260M195M211M233.13K188M200M200M
Selling and marketing
6.46B2.92B2.89B3.08B3.17B3.33B3.46B4.07B3.4B5.6B
Total operating expenses
12.45B516.80M545.81M575.83M552.17M605.47M732.18M684.66M546.36M8.9B
Operating income
6.99B504.53M605.79M523.60M486.94M665.88M751.85M780.37M643.18M8.4B
Other income (expenses), net
-1.28B-1.26B-71.41M-135.07M-1.53B-500.15M-227.76M13M-221.31M-1.9B
Income before tax
5.71B368.82M534.38M388.53M267.94M165.73M524.08M456.44M421.87M6.5B
Income tax expense
1.31B74.66M108.13M77.26M52.21M47.30M87.19M80.98M124.48M1.3B
Net income
4.40B294.15M426.24M286.03M310.07M149.23M469.13M375.46M297.38M5.2B
Earnings per share
Basic EPS
9.910.660.940.630.680.331.030.820.6511.4
Diluted EPS
9.910.660.940.630.680.331.030.820.6511.4